HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Type II citrullinaemia (citrin deficiency) in a neonate with hypergalactosaemia detected by mass screening.

Abstract
Type II citrullinaemia (CTLN2) is an adult- or late childhood-onset liver disease characterized by a liver-specific defect in argininosuccinate synthetase protein. The enzyme abnormality is caused by deficiency of the protein citrin, which is encoded by the SLC25A 13 gene. Until now, however, few cases with SLC25A13 mutations have been reported in children with liver disease. We describe an infant who presented with neonatal hepatitis in association with hypergalactosaemia detected by neonatal mass screening. DNA analysis of SLC25A13 revealed that the patient was homozygous for a IVS11+1G>A mutation. This case suggests that SLC25A13 mutant should be suspected in neonatal patients with hypergalactosaemia of unknown cause.
AuthorsE Naito, M Ito, S Matsuura, Yokota, T Saijo, Y Ogawa, S Kitamura, K Kobayashi, T Saheki, Y Nishimura, N Sakura, Y Kuroda
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 25 Issue 1 Pg. 71-6 (Feb 2002) ISSN: 0141-8955 [Print] Netherlands
PMID11999983 (Publication Type: Journal Article)
Chemical References
  • Membrane Transport Proteins
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Proteins
  • SLC25A13 protein, human
  • Galactose
Topics
  • Citrullinemia (blood, complications, genetics, physiopathology)
  • Female
  • Galactose (blood)
  • Galactosemias (blood, complications, genetics)
  • Humans
  • Infant, Newborn
  • Mass Screening
  • Membrane Transport Proteins (genetics)
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: